Overview
Kamil Kosmider practices in Lublin, Poland. Kosmider is rated as an Experienced expert by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Their top areas of expertise are Nijmegen Breakage Syndrome, Optic Glioma, Atelosteogenesis Type 1, and Neurofibromatosis Type 1 (NF1).
Their clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Acute Lymphoblastic Leukemia (ALL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Nijmegen Breakage SyndromeKosmider isAdvanced. Learn about Nijmegen Breakage Syndrome.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Kosmider isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Atelosteogenesis Type 1Kosmider isExperienced. Learn about Atelosteogenesis Type 1.
- NeurofibromatosisKosmider isExperienced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Kosmider isExperienced. Learn about Neurofibromatosis Type 1 (NF1).
- Optic GliomaKosmider isExperienced. Learn about Optic Glioma.